Financials

News Discussions Technicals Forecast Seasonals

1SXP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SCHOTT PHARMA AG & CO. KGAA operating, investing, and financing activities

1SXP free cash flow for Q1 25 is 3.29 M EUR. For 2024, 1SXP free cash flow was 80.25 M EUR and operating cash flow was 225.33 M EUR.

Q4 '22

Q1 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

Q4 '22

Q1 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—